Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia

May 24, 2016 updated by: University of British Columbia
The purpose of this study is to determine whether consumption of thiamin fortified fish sauce over 6 months increases the thiamin status of women to a level consistent with a low risk of infantile beriberi. The investigators hypothesize that consumption of thiamin-fortified fish sauce will increase red blood cell thiamin concentrations, an indicator of thiamin status, in women consuming thiamin-fortified fish sauce, while concentrations will not change in women consuming a placebo fish sauce that does not contain thiamin.

Study Overview

Detailed Description

Purpose The purpose of this three-armed, double blind randomized control trial is to determine whether thiamin-fortified fish sauce is an efficacious means of increasing dietary thiamin intake in Cambodian women to a level that increases erythrocyte thiamin diphosphate (TDP) concentrations to a level consistent with a low risk of infantile beriberi. Two groups of women will participate in this study: women of childbearing age (18-45y; n=270), and pregnant women (18-45y; ~26 weeks pregnant at baseline; n=90).

Hypothesis Intervention with thiamin-fortified fish sauce will increase women's TDP concentrations to levels consistent with a low risk of infantile beriberi compared to those receiving the control fish sauce.

Study Justification Beriberi is a micronutrient deficiency disease caused by a lack of thiamin (vitamin B1) in the diet. Infantile beriberi is common in Southeast Asia.

Beriberi, a disease caused by severe thiamin deficiency, is rare in the west but is thought to be more common in developing countries, particularly those in Southeast Asia. In infants, beriberi presents with symptoms of heart failure and is fatal unless thiamin treatment is initiated immediately. Beriberi typically presents in exclusively breastfed infants whose mothers have suboptimal thiamin status and consequently have low breast milk thiamin concentrations. Maternal thiamin deficiency in Cambodia is likely a result of multiple factors: the high consumption of white, polished rice, which has been removed from its B-vitamin-containing husk, a lack of parboiling rice, and low dietary diversity. Improving the thiamin status of pregnant and lactating women is essential for combating infantile beriberi. Fortification of a food staple has proven to be a successful strategy in increasing population levels of thiamin because as a 'passive' intervention, it requires little to no behavior change. Fish sauce is an ideal vehicle for thiamin fortification: it is consumed daily in consistently high quantities, and is produced in centralized plants, and has been successfully used in Cambodia and Vietnam as a vehicle for iron fortification.

Research Method All villages in Prey Veng province that are not already involved in an active intervention (for example, homestead food production, micronutrient powder intervention etc) will be randomized. A Khmer-speaking research assistant will contact the Village Chief and/or Village Health Volunteer in the first village on the randomized list and determine the number of eligible women of childbearing age and pregnant women (~26 weeks) in that village. The research assistant will move down the randomized list of villages until 360 participants have been enrolled. The investigators expect enrolment from approximately 10 villages.

A trained, Khmer-speaking enumerator will conduct an interview in the participants home. The questionnaire will collect demographic data, as well as information on dietary intake (including fish sauce), thoughts and perceptions of fortified products, and knowledge of thiamin deficiency and beriberi. Once the questionnaire is complete the participant will walk with the interviewer to a central meeting spot within the village (typically the Village Chief's home) to complete anthropometric measurements (height and weight). The next morning the participant will travel to the local health centre for a non-fasted blood draw.

Once the participant completes the baseline questionnaire, anthropometrics, and blood collection she will be randomly assigned to one of the three treatment groups: low concentration thiamin-iron-fortified fish sauce (2mg thiamin/mL fish sauce + iron), higher concentration thiamin-fortified fish sauce (8mg thiamin/mL fish sauce + iron), or placebo: iron-fortified fish sauce. The bottles and labels of the three fish sauces will be identical in appearance, except for a code that differentiates the sauces.

All participants will be visited biweekly for monitoring and evaluation of fish sauce consumption. Fish sauce will be distributed during these visits to ensure that there are no 'stock outs' of fish sauce during the study.

Within the first month of the study all participants will attend an educational workshop with training regarding dietary thiamin intake, thiamin deficiency and beriberi, and infant and young child feeding (IYCF) practices.

Anthropometric measurements (weight and length) will be taken within 72 hours of the birth of the participant's infant (t~3 months).

At t~4 months, a subset of households (n=28) will participate in an Observed Weighed Fish Sauce Record wherein a trained enumerator measure all fish sauce consumed by the participant throughout one day. Two repeat observed weighed fish sauce records will be completed within a 2 week period.

At endline (t=6 months), the questionnaire, anthropometrics, and blood draw will be repeated with all women. The investigators will also collect a venous blood sample (4mL) from the infant, and a breast milk sample from mothers from the pregnant cohort. Investigators plan to analyze all samples within two months of the endline sample collection, and will return to the villages to share study findings with all participants at a community meeting (general results shared), and then separately to share individual thiamin results one-on-one. All participants will have already participated in an educational workshop highlighting the importance of dietary thiamin intake, and the signs of thiamin deficiency and beriberi. Individuals with suboptimal thiamin status will be encouraged to speak with their healthcare provider, and will also be counselled using the materials that were previously used in the educational workshop.

Study Type

Interventional

Enrollment (Actual)

366

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Prey Veng
      • (Various Villages), Prey Veng, Cambodia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Women of Childbearing Age Cohort:

  • be the female head of their household,
  • have at least one child between 12 - 59 months of age at baseline,
  • be living in Prey Veng province, Cambodia, and not planning to move in the next six months,
  • agree to exclusively feed her entire household the study fish sauce for six months, and
  • be willing to provide venous blood samples at baseline and endline.

Pregnant Women Cohort:

  • be the female head of their household,
  • be ~3-8 mo pregnant with a singleton fetus at baseline,
  • have no prior history of preeclampsia, pre-term delivery, or birth defects,
  • know her approximate due date,
  • be living in Prey Veng province, Cambodia, and not planning to move in the next six months,
  • agree to exclusively feed her entire household the study fish sauce for six months, and
  • be willing to provide venous blood samples at baseline and endline, a breast milk sample at endline, and to allow for a blood sample to be taken from her infant (aged ~3 months) at endline.

Exclusion Criteria:

Women of Childbearing Age Cohort:

  • not be receiving any other intervention (for example, homestead food production),
  • not be pregnant or hoping to become pregnant within the next 6 months, and
  • not be taking any supplement that contains thiamin.

Pregnant Women Cohort:

  • not be receiving any other intervention (for example, homestead food production), and
  • not be taking any supplement that contains thiamin.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: low [thiamin] fortified fish sauce
Fish sauce will contain 2 mg thiamin hydrochloride / mL fish sauce + iron (as NaFeEDTA)
Low concentration thiamin fortified fish sauce will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.
Active Comparator: higher [thiamin] fortified fish sauce
Fish sauce will contain 8 mg thiamin hydrochloride / mL fish sauce + iron (as NaFeEDTA)
Higher concentration thiamin fortified fish sauce will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.
Placebo Comparator: Placebo fish sauce
Fish sauce will contain only iron (as NaFeEDTA), no thiamin
Fish sauce fortified only with iron, not thiamin, will be consumed ad libitum for 6 months, with biweekly monitoring and evaluation to assess fish sauce usage by household and to re-stock fish sauce within the home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Erythrocyte thiamin diphosphate
Time Frame: Baseline (t=0), Endline (t=6 months)
Measurement at baseline and endline for all women. Blood samples from infants of women recruited in the pregnancy cohort will be collected at endline only.
Baseline (t=0), Endline (t=6 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast milk thiamin concentration
Time Frame: Endline (t=6 months)
Breast milk will collected only from those women recruited in the pregnancy cohort (n=90)
Endline (t=6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tim J Green, PhD, University of British Columbia
  • Study Director: Kyly C Whitfield, MSc, University of British Columbia
  • Study Chair: Judy McLean, PhD, University of British Columbia
  • Study Chair: Zaman Talukder, MPH, Helen Keller International

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

August 18, 2014

First Submitted That Met QC Criteria

August 18, 2014

First Posted (Estimate)

August 20, 2014

Study Record Updates

Last Update Posted (Estimate)

May 25, 2016

Last Update Submitted That Met QC Criteria

May 24, 2016

Last Verified

May 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thiamin Deficiency

3
Subscribe